Researchers sought to determine whether mosunetuzumab would be effective for treating relapsed/refractory FL in patients with 2 or more prior lines of therapy.
Researchers sought to determine whether treatment of CD30-positive lymphomas with an innate cell engager would be effective.
The 5-year progression-free survival rate was significantly better in patients who underwent ASCT compared with those who did not.
Researchers sought to determine the optimal dosing for venetoclax in combination with ibrutinib for patients with relapsed or refractory MCL.
No differences in EFS or OS seen with/without bortezomib overall or in patients with T-cell acute lymphoblastic leukemia
Researchers sought to develop a prognostic model for outcomes in pediatric patients with classical Hodgkin lymphoma based on gene expression data.
The approval was based on data from the phase 3 ZUMA-7 trial.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Researchers sought to develop a model to classify patients with diffuse large B-cell lymphoma into prognostic subgroups.
Researchers sought to determine whether adding venetoclax to R-EPOCH would induce durable responses in patients with Richter syndrome.
